摘要
我们的目的是调查在健康受试者和阿尔茨海默氏病患者(AD)或轻度认知障碍患者(MCI)静息状态网络间的活动及其连通性(RSNS)。磁共振成像(MRI)和静息态MRI对诊断为AD的患者(n = 18)或MCI(n = 16)和健康受试者(n = 18)与之匹配的人口学特征(年龄、性别、教育程度)。独立成分分析和Granger因果分析(GCA)应用于图像处理中。我们计算‘In + Out degree’为每个RSN。然后,我们调查了‘In + Out degree’的每个脑网络和认知行为数据之间的关系。采用最优匹配的方法获得了最强。五个RSNs的核心区在AD,MCI和健康对照组之间类似,但在这五个RSNs之内的活性在AD和MCI组较健康对照组显著降低(P<0.01,错误发现率修正)。该结果表明,五个RSNs水平之间的连接,特别是从默认模式网络的连通性(DMN)的水平,略低于MCI患者和显著低于AD患者相比于健康受试者。相反,存储网络和在AD和MCI患者的执行控制网络之间的联系增加明显。DMN的“In + Out degree”与蒙特利尔认知评估量表评分呈负相关(R=-0.43, P<0.05)。总之,在RSNs之内的活性与RSNs之间的连接性在AD患者,MCI患者,和正常人之间是不同的;这些结果为阿尔茨海默病的诊断及疾病进展的测量和揭示疾病的发病机制提供了影像学依据。
关键词: 阿尔茨海默病(AD)、轻度认知障碍(MCI),老年痴呆症,静息状态网络(RSNS),静息状态下的功能磁共振成像(RS-fMRI),独立成分分析(ICA)、Granger因果分析(GCA)。
Current Alzheimer Research
Title:Functional Activity and Connectivity Differences of Five Resting-State Networks in Patients with Alzheimer’s Disease or Mild Cognitive Impairment
Volume: 13 Issue: 3
Author(s): Yu Chen, Hao Yan, Zaizhu Han, Yanchao Bi, Hongyan Chen, Jia Liu, Meiru Wu, Yongjun Wang, Yumei Zhang
Affiliation:
关键词: 阿尔茨海默病(AD)、轻度认知障碍(MCI),老年痴呆症,静息状态网络(RSNS),静息状态下的功能磁共振成像(RS-fMRI),独立成分分析(ICA)、Granger因果分析(GCA)。
摘要: We aimed to investigate the activity within and the connectivity between resting state networks (RSNs) in healthy subjects and patients with Alzheimer’s disease (AD) or mild cognitive impairment (MCI). Magnetic resonance imaging (MRI) and resting-state MRI were performed on patients diagnosed with AD (n=18) or MCI (n=16) and on healthy subjects (n=18) with matching demographic characteristics (age, sex, and education level). Independent component analysis and Granger causality analysis (GCA) were used during image postprocessing. We calculated ‘In + Out degree’ for each RSN. Then, we investigated the relationships between “In + Out degree” of each brain network and the cognitive behavioural data. RSNs were obtained using the optimal matching method. The core areas of the five RSNs were similar between the AD, MCI, and healthy control groups, but the activity within these five RSNs was significantly lower in the AD and MCI groups than in the healthy control group (P<0.01, false discovery rate corrected). The GCA results showed that the connectivity between the five RSNs, particularly the connectivity from the default mode network (DMN) to the other RSNs, was slightly lower in MCI patients and was significantly lower in AD patients than in healthy subjects. In contrast, increased connectivity was evident between the memory network and the executive control network in the AD and MCI patients. The “In + Out degree” of the DMN negatively correlated with the Montreal Cognitive Assessment score in AD patients (R=-0.43, P<0.05). In conclusion, the activity within RSNs and the connectivity between RSNs differed between AD patients, MCI patients, and normal individuals; these results provide an imaging reference for the diagnosis of AD and the measurement of disease progression and reveal insight into the pathogenesis of AD.
Export Options
About this article
Cite this article as:
Yu Chen, Hao Yan, Zaizhu Han, Yanchao Bi, Hongyan Chen, Jia Liu, Meiru Wu, Yongjun Wang, Yumei Zhang , Functional Activity and Connectivity Differences of Five Resting-State Networks in Patients with Alzheimer’s Disease or Mild Cognitive Impairment, Current Alzheimer Research 2016; 13 (3) . https://dx.doi.org/10.2174/156720501303160217113858
DOI https://dx.doi.org/10.2174/156720501303160217113858 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Expression of Rab3b in Human Glioma: Influence on Cell Proliferation and Apoptosis
Current Pharmaceutical Design Development of Therapeutics for High Grade Gliomas Using Orthotopic Rodent Models
Current Medicinal Chemistry Caspase-Independent Pathways of Programmed Cell Death: The Unraveling of New Targets of Cancer Therapy?
Current Cancer Drug Targets Annexins as Neuroprotective Agents in the Central Nervous System
Current Medicinal Chemistry - Central Nervous System Agents The Scatter Factor Signaling Pathways as Therapeutic Associated Target in Cancer Treatment
Current Medicinal Chemistry Recent Progress on Antifungal Drug Development
Current Pharmaceutical Biotechnology Current Protein-based Anti-angiogenic Therapeutics
Mini-Reviews in Medicinal Chemistry Xenobiotic Sulphation and its Variability During Inflammation: a Factor in Adverse Drug Reactions?
Current Drug Metabolism Ethanol Metabolism and Effects: Nitric Oxide and its Interaction
Current Clinical Pharmacology Anti-glioma Effects of Caffeic Acid Phenethyl Ester and Dasatinib Combination Therapy in an in vivo Rat Glioma Model
Anti-Cancer Agents in Medicinal Chemistry Anti-breast Cancer Agents, Quinolines, Targeting Gap Junction
Medicinal Chemistry Biocompatible Targeting Hydrogels for Breast Cancer Treatment
Mini-Reviews in Medicinal Chemistry It is All About Proteases: From Drug Delivery to In Vivo Imaging and Photomedicine
Current Medicinal Chemistry Brain Inflammation, Cholesterol, and Glutamate as Interconnected Participants in the Pathology of Alzheimers Disease
Current Pharmaceutical Design Ultrasound-Targeted Delivery Technology: A Novel Strategy for Tumor- Targeted Therapy
Current Drug Targets Molecular Imaging of Brain Tumors Personal Experience and Review of the Literature
Current Molecular Medicine Implications of PEGylation of Carbon Nanotubes for Central Nervous System Bioavailability
CNS & Neurological Disorders - Drug Targets An Analysis of Structure-function Co-relation between GLI Oncoprotein and HLA Immune-gene Transcriptional Regulation through Molecular Docking
Current Cancer Therapy Reviews Ex Vivo Gene Therapy and Vision
Current Gene Therapy NF-κB Blockers Gifted by Mother Nature: Prospectives in Cancer Cell Chemosensitization
Current Pharmaceutical Design